In the studies conducted by Nisula et al., the conclusions drawn from the analyses indicate that IL-18 may have a weak or moderate predictive value for AKI, RRT (renal replacement therapy) or 90-day mortality in ICU patients. Here, IL18 is linked to acute kidney injury.